Gilead defeats US govt in billion-dollar HIV drug patent suit

Jury finds three US government patents over PrEP to be invalid | Case thought to be the first time US government has sued a pharmaceutical firm over patents.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Gilead and Teva prevail in $3.6bn antitrust trial

4 July 2023 Verdict confirms legality of 2014 patent settlement, dismissing allegations of anti competitive practices.

Americas

Gilead avoids $1.2bn patent clash at SCOTUS

10 January 2023 Subsidiary held that its arguments were same as those cited in the much-anticipated Amgen v Sanofi | Dispute concerns a cancer treatment used to treat B-cell lymphoma.

Big Pharma

Trial set for Gilead HIV antitrust claims case

23 February 2023 Gilead, Johnson & Johnson and others will face trial in May | Class-action suit involves allegations of anticompetitive practices.

More on this story

Big Pharma

Gilead and Teva prevail in $3.6bn antitrust trial

4 July 2023 Verdict confirms legality of 2014 patent settlement, dismissing allegations of anti competitive practices.

Americas

Gilead avoids $1.2bn patent clash at SCOTUS

10 January 2023 Subsidiary held that its arguments were same as those cited in the much-anticipated Amgen v Sanofi | Dispute concerns a cancer treatment used to treat B-cell lymphoma.

Big Pharma

Trial set for Gilead HIV antitrust claims case

23 February 2023 Gilead, Johnson & Johnson and others will face trial in May | Class-action suit involves allegations of anticompetitive practices.

More on this story

Big Pharma

Gilead and Teva prevail in $3.6bn antitrust trial

4 July 2023 Verdict confirms legality of 2014 patent settlement, dismissing allegations of anti competitive practices.

Americas

Gilead avoids $1.2bn patent clash at SCOTUS

10 January 2023 Subsidiary held that its arguments were same as those cited in the much-anticipated Amgen v Sanofi | Dispute concerns a cancer treatment used to treat B-cell lymphoma.

Big Pharma

Trial set for Gilead HIV antitrust claims case

23 February 2023 Gilead, Johnson & Johnson and others will face trial in May | Class-action suit involves allegations of anticompetitive practices.